[{"id":"8a617f1a-04a1-44fa-9406-0c4b9b9170e3","acronym":"BEAUTY","url":"https://clinicaltrials.gov/study/NCT03979508","created_at":"2021-01-18T19:34:12.469Z","updated_at":"2024-07-02T16:35:07.182Z","phase":"Phase 2","brief_title":"Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer","source_id_and_acronym":"NCT03979508 - BEAUTY","lead_sponsor":"Mayo Clinic","biomarkers":" HER-2 • ER • PGR • CD20 • JAK2 • CD8 • CDH1 • CCR4 • IL2RA • PTPRC • NCAM1 • CCR5 • CCR7 • CD14 • CD27 • GZMB • HLA-B • NLRC5 • FOXP3 • IKZF2 • IL3RA • STAT1 • CXCR3 • CXCR5 • ITGAX • PRF1 • SNAI2 • TAP1 • CCR6 • CEACAM8 • DDX58 • HLA-C • IFNL1 • IFNL2 • IFNL3 • ITGB1 • KLRB1","pipe":" | ","alterations":" JAK2 amplification","tags":["HER-2 • ER • PGR • CD20 • JAK2 • CD8 • CDH1 • CCR4 • IL2RA • PTPRC • NCAM1 • CCR5 • CCR7 • CD14 • CD27 • GZMB • HLA-B • NLRC5 • FOXP3 • IKZF2 • IL3RA • STAT1 • CXCR3 • CXCR5 • ITGAX • PRF1 • SNAI2 • TAP1 • CCR6 • CEACAM8 • DDX58 • HLA-C • IFNL1 • IFNL2 • IFNL3 • ITGB1 • KLRB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JAK2 amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Verzenio (abemaciclib)"],"overall_status":"Recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 01/10/2020","start_date":" 01/10/2020","primary_txt":" Primary completion: 07/31/2024","primary_completion_date":" 07/31/2024","study_txt":" Completion: 07/31/2024","study_completion_date":" 07/31/2024","last_update_posted":"2024-04-29"},{"id":"b9788ba4-b64a-46d6-86b9-14d897604bd6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05291338","created_at":"2022-07-18T07:54:47.484Z","updated_at":"2024-07-02T16:35:41.653Z","phase":"","brief_title":"Pharmacogenetic Study in Hepatocellular Carcinoma Patients.","source_id_and_acronym":"NCT05291338","lead_sponsor":"Rehab Werida","biomarkers":" IFNL3","pipe":"","alterations":" ","tags":["IFNL3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e doxorubicin hydrochloride"],"overall_status":"Completed","enrollment":" Enrollment 107","initiation":"Initiation: 01/01/2022","start_date":" 01/01/2022","primary_txt":" Primary completion: 03/31/2023","primary_completion_date":" 03/31/2023","study_txt":" Completion: 04/01/2023","study_completion_date":" 04/01/2023","last_update_posted":"2023-07-28"},{"id":"3629edc5-f527-4087-a4f7-97f634c0b8f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT01544920","created_at":"2022-07-18T07:54:24.897Z","updated_at":"2024-07-02T16:37:07.027Z","phase":"Phase 3","brief_title":"Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)","source_id_and_acronym":"NCT01544920","lead_sponsor":"Merck Sharp \u0026 Dohme LLC","biomarkers":" IFNL3","pipe":"","alterations":" ","tags":["IFNL3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Pegasys (pegylated interferon α -2a) • ViraferonPeg (peginterferon-α-2b)"],"overall_status":"Completed","enrollment":" Enrollment 737","initiation":"Initiation: 05/30/2012","start_date":" 05/30/2012","primary_txt":" Primary completion: 05/19/2015","primary_completion_date":" 05/19/2015","study_txt":" Completion: 05/19/2015","study_completion_date":" 05/19/2015","last_update_posted":"2018-09-11"},{"id":"2cfb63f8-caef-4e92-b1d4-4723a0502155","acronym":"","url":"https://clinicaltrials.gov/study/NCT01463956","created_at":"2021-10-27T14:53:03.432Z","updated_at":"2025-02-25T16:02:01.047Z","phase":"Phase 2","brief_title":"Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation","source_id_and_acronym":"NCT01463956","lead_sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","biomarkers":" IFNL3 • ITPA","pipe":"","alterations":" ","tags":["IFNL3 • ITPA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ViraferonPeg (peginterferon-α-2b)"],"overall_status":"Completed","enrollment":" Enrollment 58","initiation":"Initiation: 01/06/2012","start_date":" 01/06/2012","primary_txt":" Primary completion: 06/01/2014","primary_completion_date":" 06/01/2014","study_txt":" Completion: 01/22/2015","study_completion_date":" 01/22/2015","last_update_posted":"2017-01-24"}]